2001-January Archives by Date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Tue Jan 2 10:06:04 2001
Ending: Wed Jan 31 13:21:07 2001
Messages: 71

• [Pharm-policy] Justin Gillis on Canavan gene patent   James Love
• [Pharm-policy] Washington Post editorial on US parallel import legislation   James Love
• [Pharm-policy] HHS Secretary Ashcroft "Ties to White Supremacists"   Paul Davis
• [Pharm-policy] Correction: Ashcroft for AG, _not_ HHS   Paul Davis
• [Pharm-policy] Bush Transition team members for DHHS   Mike Palmedo
• [Pharm-policy] India dispute over WTO EMR transition rules   James Love
• [Pharm-policy] Susan Finston of PhRMA on India EMR dispute   James Love
• [Pharm-policy] Glaxo among 10 Worst Corporations of 2000   Robert Weissman
• [Pharm-policy] Patent Office to Issue New Gene Guidelines   James Love
• [Pharm-policy] US PTO Utility Examination Guidelines   James Love
• [Pharm-policy] Rep Thomas/USTR/Accussations to foreigns   MFJorge@aol.com
• [Pharm-policy] Interview with WIPO's Kifle Shenkoru   love@cptech.org
• [Pharm-policy] Australia studies pharmaceutical prices   James Love
• [Pharm-policy] Bernie Sanders to WP on US reimportation bill   James Love
• [Pharm-policy] Don McNeil in NYT on Romania's AIDS Children   James Love
• [Pharm-policy] (no subject)   love@cptech.org
• [Pharm-policy] Access to fluconazole in less-developed countries   James Love
• [Pharm-policy] Re: CD 4 count information   James Love
• [Pharm-policy] CD 4 count information   stefan stojanovik
• [Pharm-policy] Canadian court ruling on trade dress   James Love
• [Pharm-policy] Re: CD 4 count information   stefan stojanovik
• [Pharm-policy] [Fwd: [Ip-health] Doctor who puts patient rights before patent rights]   Mike Palmedo
• [Pharm-policy] Re: CD 4 count information   Gonsalves, Gregg
• [Pharm-policy] Generic Claritin lawsuit   Mike Palmedo
• [Pharm-policy] URL for Canada trade dress case   James Love
• [Pharm-policy] Re: CD 4 count information   HERA
• [Pharm-policy] pharmaceutical multinationals are at it again in South Africa   Prof. Udo Schuklenk
• [Pharm-policy] [Fwd: [Ip-health] Lancet-Nigerian govt investiages Pfizer drug trial allegatio]   Mike Palmedo
• [Pharm-policy] Washington Post on Pfizer's Nigerian drug trials   Mike Palmedo
• [Pharm-policy] NY Times on Bayer-CuraGen agreement   Mike Palmedo
• [Pharm-policy] South Africa fights Aids drug apartheid   Mike Palmedo
• [Pharm-policy] Drug company funding of patient groups in Australia   love@cptech.org
• [Pharm-policy] USTR Announces Draft FTAA Text, Releases Summaries of U.S. Positions   Robert Weissman
• [Pharm-policy] Summary of US IP position for FTAA (fwd)   Robert Weissman
• [Pharm-policy] The Big Drug Run To The Border   Dean Hughson
• [Pharm-policy] The Big Drug Run To The Border   James Love
• [Pharm-policy] Davis and Arno: Why Don't We Enforce Existing Drug Price Controls?   James Love
• [Pharm-policy] looking for data on IPR litigation costs   James Love
• [Pharm-policy] Antitrust Issues in Settlement of Pharmaceutical Patent Disputes   James Love
• [Pharm-policy] News from Bangkok   Alacran7@aol.com
• [Pharm-policy] Query on UN General Assemblyu   P. Davis
• [Pharm-policy] Audit finds Medicare paid twice as much as veterans for same drugs   James Love
• [Pharm-policy] Recommended state practice for compulsory licensing   James Love
• [Pharm-policy] Bush considers reversing Africa Executive Order   James Love
• [Pharm-policy] Section 15c of the South Africa Medicines Act   James Love
• [Pharm-policy] UK: Bayer in Illegal Drug Trial   Mike Palmedo
• [Pharm-policy] London Sunday Times on Bayer drug trials   Mike Palmedo
• [Pharm-policy] Counterfeiting problems in China   James Love
• [Pharm-policy] a better (private) Medicare prescription benefit plan   pill@shorenetworks.com
• [Pharm-policy] a better (private) prescription for Medicare   pill@shorenetworks.com
• [Pharm-policy] Text of the Africa/HIV/AIDS executive order 13155   James Love
• [Pharm-policy] Re:Ideas on Access to Drugs Issues   Paul Davis
• [Pharm-policy] Glaxo plan to block generic Paxil, US Judge won't unseal documents   love@cptech.org
• [Pharm-policy] Susan Finston: More on India and the EMR Application Process   James Love
• [Pharm-policy] HIV testing patents   love@cptech.org
• [Pharm-policy] Glaxo closes SA drug factor, TAC says nationalize and produce generics   love@cptech.org
• [Pharm-policy] Tina Rosenberg's NYT Magazine article on HIV/AIDS crisis   love@cptech.org
• [Pharm-policy] Essential Action/CPTech Comments on US-Chile FTA   Robert Weissman
• [Pharm-policy] CIPLA requests licenses from Glaxo, Pfizer, BMS, and BI   love@cptech.org
• [Pharm-policy] [Toronto Globel and Mail] J'accuse!   Gordon Irlam
• [Pharm-policy] Nairobi press on South Africa lawsuit over medicines act   love@cptech.org
• [Pharm-policy] Merck collaboration with rivals   love@cptech.org
• [Pharm-policy] Re: [Ip-health] Re:Ideas on Access to Drugs Issues   Professor Olive Shisana
• [Pharm-policy] RE: [Ip-health] Susan Finston: More on India and the EMR Applicat ion Process   Dehoney, Eleanor
• [Pharm-policy] Re: [Ip-health] HIV testing patents   Gregg Gonsalves
• [Pharm-policy] [Toronto] Globe & Mail editorial - Jan 29, 2001   Richard Elliott
• [Pharm-policy] Uganda: Glaxo's letter to Cipla regarding sales of AZT and 3TC   James Love
• [Pharm-policy] CSU v. Xerox brief   James Love
• [Pharm-policy] Zoellick comments in Senate re Africa Exec Order   James Love
• [Pharm-policy] India: Pharma industry demands tax exemption during R&D operations   love@cptech.org
• [Pharm-policy] USTR out-of-cycle reviews   Mike Palmedo

Last message date: Wed Jan 31 13:21:07 2001
Archived on: Wed Jan 31 13:21:07 2001

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...